Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 9
2010 5
2011 3
2012 6
2013 6
2014 11
2015 7
2016 4
2017 6
2018 6
2019 6
2020 14
2021 18
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Results by year
Filters applied: . Clear all
Page 1
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
Montal R, Sia D, Montironi C, Leow WQ, Esteban-Fabró R, Pinyol R, Torres-Martin M, Bassaganyas L, Moeini A, Peix J, Cabellos L, Maeda M, Villacorta-Martin C, Tabrizian P, Rodriguez-Carunchio L, Castellano G, Sempoux C, Minguez B, Pawlik TM, Labgaa I, Roberts LR, Sole M, Fiel MI, Thung S, Fuster J, Roayaie S, Villanueva A, Schwartz M, Llovet JM. Montal R, et al. Among authors: tabrizian p. J Hepatol. 2020 Aug;73(2):315-327. doi: 10.1016/j.jhep.2020.03.008. Epub 2020 Mar 12. J Hepatol. 2020. PMID: 32173382 Free PMC article.
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma.
Jühling F, Hamdane N, Crouchet E, Li S, El Saghire H, Mukherji A, Fujiwara N, Oudot MA, Thumann C, Saviano A, Roca Suarez AA, Goto K, Masia R, Sojoodi M, Arora G, Aikata H, Ono A, Tabrizian P, Schwartz M, Polyak SJ, Davidson I, Schmidl C, Bock C, Schuster C, Chayama K, Pessaux P, Tanabe KK, Hoshida Y, Zeisel MB, Duong FH, Fuchs BC, Baumert TF. Jühling F, et al. Among authors: tabrizian p. Gut. 2021 Jan;70(1):157-169. doi: 10.1136/gutjnl-2019-318918. Epub 2020 Mar 26. Gut. 2021. PMID: 32217639 Free PMC article.
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
von Felden J, Craig AJ, Garcia-Lezana T, Labgaa I, Haber PK, D'Avola D, Asgharpour A, Dieterich D, Bonaccorso A, Torres-Martin M, Sia D, Sung MW, Tabrizian P, Schwartz M, Llovet JM, Villanueva A. von Felden J, et al. Among authors: tabrizian p. Oncogene. 2021 Jan;40(1):140-151. doi: 10.1038/s41388-020-01519-1. Epub 2020 Oct 23. Oncogene. 2021. PMID: 33097857
Gallbladder volvulus.
Moser L, Joliat GR, Tabrizian P, Di Mare L, Petermann D, Halkic N, Demartines N, Labgaa I. Moser L, et al. Among authors: tabrizian p. Hepatobiliary Surg Nutr. 2021 Apr;10(2):249-253. doi: 10.21037/hbsn-20-771. Hepatobiliary Surg Nutr. 2021. PMID: 33898569 Free PMC article. No abstract available.
Current management of hepatocellular carcinoma.
Tabrizian P, Roayaie S, Schwartz ME. Tabrizian P, et al. World J Gastroenterol. 2014 Aug 14;20(30):10223-37. doi: 10.3748/wjg.v20.i30.10223. World J Gastroenterol. 2014. PMID: 25132740 Free PMC article. Review.
PD-1 inhibitor as bridge therapy to liver transplantation?
Tabrizian P, Florman SS, Schwartz ME. Tabrizian P, et al. Am J Transplant. 2021 May;21(5):1979-1980. doi: 10.1111/ajt.16448. Epub 2021 Jan 2. Am J Transplant. 2021. PMID: 33316117 No abstract available.
85 results